The Clinigen Group PLC (CLIN) Earns Buy Rating from Peel Hunt

The Clinigen Group PLC (CLIN) Earns Buy Rating from Peel Hunt

Peel Hunt reiterated their buy rating on shares of Clinigen Group PLC (LON:CLIN) in a report issued on Tuesday. They currently have a GBX 1,000 ($12.19) price target on the stock.

Several other equities analysts also recently commented on the stock. Stifel Nicolaus reissued a buy rating and issued a GBX 800 ($9.75) price objective on shares of Clinigen Group PLC in a research note on Wednesday, September 28th. Numis Securities Ltd reissued a buy rating and issued a GBX 933 ($11.37) price objective on shares of Clinigen Group PLC in a research note on Wednesday, September 28th. Finally, N+1 Singer reissued a buy rating and issued a GBX 800 ($9.75) price objective on shares of Clinigen Group PLC in a research note on Wednesday, September 28th. Five equities research analysts have rated the stock with a buy rating, The stock presently has a consensus rating of Buy and an average target price of GBX 856.60 ($10.44).

Clinigen Group PLC (LON:CLIN) opened at 740.037048 on Tuesday. The stock has a 50 day moving average of GBX 716.80 and a 200 day moving average of GBX 621.20. Clinigen Group PLC has a one year low of GBX 492.75 and a one year high of GBX 793.50. The firm’s market cap is GBX 848.08 million.

The firm also recently declared a dividend, which will be paid on Friday, November 25th. Stockholders of record on Thursday, November 3rd will be paid a dividend of GBX 2.70 ($0.03) per share. The ex-dividend date is Thursday, November 3rd. This represents a dividend yield of 0.38%. This is an increase from Clinigen Group PLC’s previous dividend of $1.30.

In other news, insider Shaun Edward Chilton sold 97,246 shares of the firm’s stock in a transaction on Tuesday, October 18th. The shares were sold at an average price of GBX 750 ($9.14), for a total transaction of £729,345 ($888,903.11).

Related posts

Leave a Comment